Karyopharm Therapeutics Inc. · NASDAQ:KPTI
Anders Hove reported a 5.70% stake in Karyopharm Therapeutics Inc. (Schedule 13G/A)
Event Sep 22, 2026 · Filed Sep 25, 2026
Anders Hove reported a 5.70% stake in Karyopharm Therapeutics Inc., 1,284,221 shares, as a passive investor on Sep 22, 2026. Filed Sep 25, 2026 (Schedule 13G/A).
- Stake
- 5.70%
- Shares
- 1,284,221
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| ACORN BIOVENTURES, L.P. | 2.40% | 539,373 |
| ACORN CAPITAL ADVISORS GP, LLC | 2.40% | 539,373 |
| ACORN BIOVENTURES 2, L.P. | 3.30% | 744,848 |
| Acorn Capital Advisors GP 2, LLC | 3.30% | 744,848 |
| Anders Hove | 5.70% | 1,284,221 |
Source
Related
- Karyopharm Therapeutics Inc.
- Anders Hove
- Karyopharm Therapeutics Inc. shareholders
- Schedule 13G/A · Anders Hove · Oct 8, 2026
- Schedule 13G/A · Anders Hove · Sep 25, 2026
- Schedule 13G · Anders Hove · May 15, 2026
- Form 4 · Abate Kristin · Oct 19, 2026
- Form 4 · Abate Kristin · Oct 2, 2026
- Schedule 13G · Millennium Management LLC · Sep 4, 2026
- Form 4 · Abate Kristin · Sep 2, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026